SEC Form 4 · accession 0001127602-15-019694
LABCORP HOLDINGS INC. · LH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P King
Officer — President & CEO · Director
Period of report
Jun 1, 2015
Accepted (ET)
Jun 3, 2015 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920148
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 1, 2015 | M | 50,000 | $80.37 | A | 115,899 | D | |
| Common StockF2 | Jun 1, 2015 | S | 909 | $117.87 | D | 114,990 | D | |
| Common StockF3 | Jun 1, 2015 | S | 49,091 | $118.59 | D | 65,899 | D | |
| Common Stock | holding | — | — | — | 31,223 | I | By grantor retained annuity trust | |
| Common Stock | holding | — | — | — | 27,296 | I | By grantor retained annuity trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock OptionsF4,F5 | $80.37 | Jun 1, 2015 | M | 50,000 | D | Feb 20, 2008 | Feb 20, 2017 | Common Stock | 50,000 | 100,000 | D |
Explanation of responses
- F1Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
- F2The price of $117.8687 per share represents a weighted average of sales prices ranging from $117.75 to $117.99 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- F3The price of $118.5882 per share represents a weighted average of sales prices ranging from $118.00 to $118.86 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- F4Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2000 Stock Incentive Plan.
- F5The option vested in three equal annual installments beginning on 02/20/2008 and is now fully exercisable.